大北农(002385) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥8,264,903,565.21, a decrease of 5.02% compared to the same period last year[6]. - The net profit attributable to shareholders was -¥134,355,784.08, representing a decline of 174.84% year-on-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥201,758,520.40, a decrease of 223.10% compared to the previous year[6]. - The company reported a net loss of CNY 1,150,281,520.44 for Q3 2023, worsening from a loss of CNY 259,967,540.99 in Q3 2022[31]. - The total comprehensive income attributable to the parent company for Q3 2023 was -¥917,627,281.19, compared to -¥381,736,442.24 in the same period last year[33]. - Basic and diluted earnings per share for Q3 2023 were both -¥0.22, worsening from -¥0.08 in Q3 2022[33]. Assets and Liabilities - The total assets at the end of the reporting period were ¥31,540,998,887.05, an increase of 1.08% from the end of the previous year[6]. - The equity attributable to shareholders decreased by 10.06% to ¥9,682,655,852.60 compared to the end of the previous year[6]. - The company's total liabilities reached CNY 19,869,945,151.18, up from CNY 18,212,776,548.75, reflecting an increase of about 9.1%[28]. - Total current assets amount to approximately 12.88 billion yuan, an increase from 12.66 billion yuan at the beginning of the year[26]. - Non-current assets totaled CNY 18,665,314,676.63 as of September 30, 2023, slightly up from CNY 18,575,168,419.22 at the beginning of the year[27]. - The company's cash and cash equivalents decreased from approximately 5.77 billion yuan at the beginning of the year to about 5.28 billion yuan[25]. Cash Flow - The company's cash flow from operating activities was negative at -¥55,542,869.07, a decline of 109.22% compared to the previous year[6]. - Cash inflows from operating activities for Q3 2023 totaled ¥24,294,158,519.97, an increase from ¥22,419,130,837.99 in Q3 2022[34]. - Cash outflows from operating activities for Q3 2023 were ¥24,349,701,389.04, compared to ¥21,816,567,783.89 in the previous year, resulting in a net cash flow from operating activities of -¥55,542,869.07[35]. - Cash inflows from investing activities for Q3 2023 were ¥280,059,515.34, up from ¥97,560,272.83 in Q3 2022[35]. - Cash outflows from investing activities for Q3 2023 were ¥1,332,348,607.85, significantly lower than ¥3,009,907,019.42 in the same period last year[35]. - Cash inflows from financing activities for Q3 2023 totaled ¥8,307,860,132.59, compared to ¥7,356,736,071.47 in Q3 2022[36]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 235,411[15]. - The largest shareholder, Shao Genhuo, holds 24.51% of the shares, amounting to 1,014,200,026 shares, with 404,223,000 shares pledged[16]. Legal Matters - The company is involved in a lawsuit to recover a CNY 500 million advance payment related to the acquisition of eight feed companies from Jiangxi Zhengbang Technology Co., Ltd. due to breach of contract[19]. - As of September 30, 2023, the estimated provision for equity loss related to Zhengbang Technology amounts to 200 million yuan[20]. - The company has recognized a contingent liability of 12,849,713.80 yuan related to the ongoing litigation with Jiuding Technology as of September 30, 2023[22]. - The company is actively appealing a court ruling regarding the acquisition of Jiuding Technology, which requires a payment of 396 million yuan plus late fees[21]. Investment Activities - The company has acquired 30% equity in Hunan Jiuding Technology (Group) Co., Ltd. for 1.32 billion yuan, with a first payment of 660 million yuan made[20]. - The company plans to issue no more than 414,128,185 shares of A-shares, raising up to 2.26 billion yuan, later adjusted to a maximum of 1.9429617 billion yuan[22]. Operational Metrics - Accounts receivable increased by ¥911,322,500, a growth of 93.21% due to increased credit limits for certain customers[9]. - Contract liabilities increased by ¥855,662,300, a growth of 109.76% due to increased advance payments received[10]. - The company reported a significant increase in asset impairment losses, which rose by 604.80% year-on-year to ¥20,889,700[11]. - Research and development expenses for Q3 2023 amounted to CNY 509,949,229.43, compared to CNY 432,878,804.65 in Q3 2022, reflecting a rise of approximately 17.8%[31].